Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
-
Published:2022-11-13
Issue:11
Volume:12
Page:1109
-
ISSN:2218-1989
-
Container-title:Metabolites
-
language:en
-
Short-container-title:Metabolites
Author:
Abd-Alla Howaida I., Kutkat Omnia, Sweelam Heba-tollah M., Eldehna Wagdy M.ORCID, Mostafa Marwa A., Ibrahim Magda T., Moatasim YassminORCID, GabAllah Mohamed, Al-Karmalawy Ahmed A.ORCID
Abstract
The anti-MERS-CoV activities of three medicinal plants (Azadirachta indica, Artemisia judaica, and Sophora tomentosa) were evaluated. The highest viral inhibition percentage (96%) was recorded for S. tomentosa. Moreover, the mode of action for both S. tomentosa and A. judaica showed 99.5% and 92% inhibition, respectively, with virucidal as the main mode of action. Furthermore, the anti-MERS-CoV and anti-SARS-CoV-2 activities of S. tomentosa were measured. Notably, the anti-SARS-CoV-2 activity of S. tomentosa was very high (100%) and anti-MERS-CoV inhibition was slightly lower (96%). Therefore, the phytochemical investigation of the very promising S. tomentosa L. led to the isolation and structural identification of nine compounds (1–9). Then, both the CC50 and IC50 values for the isolated compounds against SARS-CoV-2 were measured. Compound 4 (genistein 4’-methyl ether) achieved superior anti-SARS-CoV-2 activity with an IC50 value of 2.13 µm. Interestingly, the mode of action of S. tomentosa against SARS-CoV-2 showed that both virucidal and adsorption mechanisms were very effective. Additionally, the IC50 values of S. tomentosa against SARS-CoV-2 and MERS-CoV were found to be 1.01 and 3.11 µg/mL, respectively. In addition, all the isolated compounds were subjected to two separate molecular docking studies against the spike (S) and main protease (Mpr°) receptors of SARS-CoV-2.
Subject
Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference75 articles.
1. Al-Karmalawy, A.A., Soltane, R., Abo Elmaaty, A., Tantawy, M.A., Antar, S.A., Yahya, G., Chrouda, A., Pashameah, R.A., Mustafa, M., Abu Mraheil, M., Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview. Vaccines, 2021. 9. 2. A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval;Ashour;Drug Des. Dev. Ther.,2022 3. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview;Rabaan;Infez Med,2020 4. Roshdy, W.H., Khalifa, M.K., San, J.E., Tegally, H., Wilkinson, E., Showky, S., Martin, D.P., Moir, M., Naguib, A., Elguindy, N., SARS-CoV-2 Genetic Diversity and Lineage Dynamics in Egypt during the First 18 Months of the Pandemic. Viruses, 2022. 14. 5. The journey of antimalarial drugs against SARS-CoV-2: Review article;Sarhan;Inform. Med. Unlocked,2021
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|